Charity Number: 282204
British Society for Haemostasis and Thrombosis
Report and financial statements
For the year ended 31 December 2024
British Society for Haemostasis and Thrombosis Reference and administrative information for the year ended 31 December 2024
Charity number 282204
Registered office and operational address
Slade & Cooper Ltd Beehive Mill, Jersey Street, Manchester, M4 6JG
Trustees
Trustees who served during the year and up to the date of this report were as follows:
Dr Cédric Duval Professor Neil Morgan Dr Josefin Ahnstroem Dr Catherine Bagot Professor Helen Philippou Dr Nicola Mutch
Bankers
Barclays Bank Plc 66 High Street Ashford Kent TN24 8TL
Investment managers
Fiske plc Salisbury House London Wall London EC2M 5QS
Accountants
Slade & Cooper Ltd Beehive Mill, Jersey Street, Manchester, M4 6JG
1
British Society for Haemostasis and Thrombosis Trustees’ annual report
for the year ended 31 December 2024
The trustees present their report and the unaudited financial statements for the year ended 31 December 2024. Reference and administrative information set out on page 1 forms part of this report.
Objectives and activities
Reference and Administrative Information
The British Society for Haemostasis and Thrombosis began operating in 1981. Most of the charity's activities are undertaken in the United Kingdom.
The Board and Senior executives of the charity are listed on page 1. Dr Cédric Duval is the trustee to whom day-to-day management of the charity was delegated by the Trustees in January 2024.
Objectives and Activities
The objectives of this Society are the advancement of public education and the promotion of those branches of medical science concerned with haemostasis and thrombosis. In furtherance of these objectives the Society holds meetings at which members of the Society and their guests present and discuss their work. A website (www.bsht.org.uk) is available to provide information, but from time to time, the Society also produces a newsletter for its membership.
The trustees have referred to the guidance contained in the Charity Commission's general guidance on public benefit when reviewing the charity's aims and objectives and in planning its future activities.
Achievements and performance
The charity's main activities and who it tries to help are described below. All its charitable activities focus on the promotion of medical science in the field of Haemostasis and Thrombosis and are undertaken to further British Society for Haemostasis and Thrombosis’s charitable purposes for the public benefit.
Travel Grants
Travel grants are available to enable investigators to visit laboratories at home or abroad (or for foreign scientists to visit members' laboratories) to gain experience in another area of haemostasis science.
Payments are for travel and subsistence. Applicants do not need to be a member of the Society but they must be sponsored by a member.
In 2024, 1 travel application was made from members and awarded amounting to £810.
Congress Bursaries
In 2024, numerous bursaries were offered or awarded for national and international meetings. The BSHT annual meeting was held as an in person meeting once again, in Belfast 24 – 26 January 2024. Bursaries/prizes were given to 5 x ‘Scientist in Training’ Speakers, totalling £1,000.
The annual ISTH congress took place in Bangkok (24 – 28 June 2024), where the Society supported 19 ECRs to attend the event totalling £17,000.
2
British Society for Haemostasis and Thrombosis Trustees’ annual report
for the year ended 31 December 2024
BSHT Undergraduate Programme
BSHT aims to attract young scientists into the field of haemostasis and thrombosis. This year 6 student awards were given alongside laboratory consumables totalling £11,400.
Educational Subcommittee Grants
The Society encourages educational meetings on specialist topics to which members of the Society are invited.
Achievements and Performance
The Society aims to spend its income from investments, as well as income from Gift Aid from its subsidiary, BSHT Meetings Ltd, after subtraction of administrative costs, on education and research.
General charitable expenditure is monitored three times year at committee meetings, where the Treasurer provides updates on the amount of income that has been spent or allocated for education and research.
Financial review
During the year, the total cash funds decreased from £65,240 to £62,029. This is due to increased bursary funding.
The Trustees confirm that the investments held by the Society have been acquired in accordance with the powers available to the Trustees.
The level of free reserves (that is, those funds not tied up in fixed assets and restricted funds) that the charity holds at 31 December 2024 is £62,029 (2023: £65,240).
Reserves policy
The Trustees do not have a formal Reserves Policy.
Plans for the future
The future plans for BSHT include continuing commitment to education in areas of Haemostasis and Thrombosis. Plans for holding educational seminars for junior doctors and scientists will be explored as will other means for encouraging recruitment to careers in this area. With the continued success of the Undergraduate Programme there is the intention to continue with this scheme.
Research will be supported by the provision of travel grants and congress bursaries and opportunities for more substantial support for research posts will be sought. The Society is committed to supporting our membership for future international meetings.
The Society will continue to develop links with other bodies sharing similar interest with a view to more collaboration.
3
British Society for Haemostasis and Thrombosis Trustees’ annual report
for the year ended 31 December 2024
Structure, governance and management
The organisation is an unincorporated charity, registered as a charity on 9 April 1981 in England and Wales.
The charity is constituted under a trust deed dated 9 March 1981. The trustees are members of the charity but this entitles them only to voting rights. The trustees have no beneficial interest in the charity. The power of appointing Trustees is vested in the President.
All trustees give their time voluntarily and receive no benefits from the charity. Any expenses reclaimed from the charity are set out in note 5 to the accounts.
Governance
The finances of the organisation are subject to regular review by the BSHT committee on behalf of the members of the organisation. All commitments are agreed by the committee and are included in the published annual report. All transactions are approved by at least two of four signatories.
Management
The Society is managed by the Executive comprising the President, President-Elect, Secretary and Treasurer. The BSHT Committee is responsible for reviewing all aspects of the activities of the organisation and all major commitments require the formal approval of the committee.
Risk Management
The Trustees confirm that they have identified and reviewed the major risks to which the charity is exposed and have established systems to mitigate those risks.
The trustees’ annual report has been approved by the trustees on 23/09/2025 and signed on their behalf by
___ Dr Cédric Duval Trustee
4
Independent examiner’s report to the trustees of
British Society for Haemostasis and Thrombosis
I report to the charity trustees on my examination of the accounts of the charity for the year ended 31[st] December 2024 which are set out on pages 6 to 7.
Responsibilities and basis of report
As the charity’s trustees you are responsible for the preparation of the accounts in accordance with the requirements of the Charities Act 2011 (‘the Act’).
I report in respect of my examination of the charity’s accounts carried out under section 145 of the Act and in carrying out my examination I have followed all the applicable Directions given by the Charity Commission under section 145(5)(b) of the Act.
Independent examiner's statement
I have completed my examination. I confirm that no matters have come to my attention in connection with the examination giving me cause to believe that in any material respect: 1. accounting records were not kept in respect of the charity as required by section 130 of the Act;
or
-
the accounts do not accord with those records; or
-
the accounts do not comply with the applicable requirements concerning the form and content of accounts set out in the Charities (Accounts and Reports) Regulations 2008 other than any requirement that the accounts give a ‘true and fair view’ which is not a matter considered as part of an independent examination.
I have no concerns and have come across no other matters in connection with the examination to which attention should be drawn in this report in order to enable a proper understanding of the accounts to be reached.
Jennifer Daniel FCCA DChA Slade & Cooper Limited Chartered Certified Accountants Beehive Mill, Jersey Street Manchester, M4 6JG
Date: 24/09/2025
5
British Society for Haemostasis and Thrombosis Receipts and Payments Account for the year ended 31 December 2024 Unrestricted funds Restricted funds Total funds 2024 Total funds 2023 Receipts Donation from subsidiary company Donation ISTH 2022 Membership fees Investment income Other income 13.494 13,494 10,667 28,874 4,025 6,443 467 4.935 7,042 880 4,935 7,042 880 Total receipts 26,351 26,351 50,476 Payments Bursary costs Bookeeping Accountancy Website Bank charges Miscellaneous 29,360 29,360 15,750 2,340 4,787 280 66 3,556 66 136 66 136 Total payments 29,562 29,562 26,779 Net re¢eipts/(payments) (3,211) (3,211) 23,697 Transfer between funds Net receipts/(payments) after transfers (3,211) (3,211) 23,697
British Society for Haemostasis and Thrombosis
Statement of assets and liabilities
as at 31 December 2024
| Unrestricted funds Note £ 65,240 (3,211) 62,029 Other assets Fund Investments Unrestricted Total other assets Liabilities Fund Creditors Unrestricted Total liabilities Cash funds Bank and cash balances at start of year Surplus / (deficit) shown on receipts and payments account Bank and cash balances at end of year |
Restricted funds £ - - - |
Total funds 2024 £ 65,240 (3,211) 62,029 2024 252,804 252,804 2024 1,008 1,008 |
Total funds 2023 £ 41,543 23,697 |
|---|---|---|---|
| 65,240 | |||
| 2023 246,818 |
|||
| 246,818 | |||
| 2023 960 |
|||
| 960 |
Approved by the Trustees on 23/09/2025 and signed on their behalf by:
Dr Cedric Duval Treasurer BSHT
7